Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
SBI Healthcare Opp Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.13.46592800000446.1100
Domestic EquitiesMax Healthcare Institute Ltd.6.49532200000215.1820
Domestic EquitiesDivi's Laboratories Ltd.6.2033375000205.5094
Domestic EquitiesCipla Ltd.5.09831200000168.9000
Domestic EquitiesLupin Ltd.4.8293840000159.9906
Domestic EquitiesMankind Pharma Ltd.3.8720560000128.2736
Domestic EquitiesAether Industries Ltd.3.61461400000119.7490
Domestic EquitiesJupiter Life Line Hospitals Ltd.3.4669800000114.8560
Domestic EquitiesPolymedicure Ltd.3.3179540000109.9170
Domestic EquitiesAbbott India Ltd.3.303036000109.4243
Domestic EquitiesKrishna Institute of Medical Sciences Ltd.3.30292100000109.4205
Domestic EquitiesAmi Organics Ltd.3.2730500000108.4325
Domestic EquitiesFortis Healthcare Ltd.3.18101720000105.3844
Domestic EquitiesAlkem Laboratories Ltd.2.804920000092.9240
Domestic EquitiesLaurus Labs Ltd.2.7053170000089.6240
Domestic EquitiesAster DM Healthcare Ltd.2.6759220000088.6490
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.669730000088.4430
Domestic EquitiesGland Pharma Ltd.2.551654438084.5313
Domestic EquitiesRainbow Children's Medicare Ltd.2.394764000079.3344
Domestic EquitiesAurobindo Pharma Ltd.2.300072000076.1976
Domestic EquitiesSuven Pharmaceuticals Ltd.1.982254060465.6672
Domestic EquitiesBiocon Ltd.1.8259200000060.4900
Domestic EquitiesVijaya Diagnostic Centre Ltd.1.658560000054.9450
Domestic EquitiesPfizer Ltd.1.222710000040.5075
Domestic EquitiesAkums Drugs & Pharmaceuticals Ltd.1.144783253237.9218
Domestic EquitiesSanofi Consumer Healthcare India Ltd.1.03067500034.1430
Domestic EquitiesGufic Biosciences Ltd.0.9978100000033.0550
Domestic EquitiesConcord Biotech Ltd.0.903220000029.9220
Total 92.2911 3057.5041
Cash & Cash Equivalents and Net AssetsTREPS2.8347 93.9105
Cash & Cash Equivalents and Net AssetsNet Receivable / Payable-0.2129 -7.0543
Total 2.6218 86.8562
Treasury Bills182 DAY T-BILL 05.06.250.08913000002.9502
Total 0.0891 2.9502
Overseas EquitiesLonza Group4.9981300000165.5804
Total 4.9981 165.5804
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.